Illinois Tool Works Inc. (ILT)
Deutsche Börse Xetra · Germany · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 238.60 |
|---|---|
| 52-week range | 207.70 – 260.40 |
| Return, 1 month / 3 months | −0.1% / −4.4% |
| Return, 1 year / 3 years | +14.8% / +20.0% |
| Trend | Uptrend |
| RSI (14) | 48 |
| Volatility (1 year) | 21.4% |
| Worst drawdown (1 year) | -17.1% |
| Average daily value traded | 0.01M EUR |
| Dividend yield | 2.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Illinois Tool Works is an industrial manufacturer based in Glenview, Illinois, in the United States. It makes a broad range of engineered products, including fasteners, adhesives, welding equipment, food service equipment, and testing and measurement instruments. Its customers are mainly businesses across industrial, automotive, construction and food service markets, and it serves them through many separate operating units, each focused on a particular product line and customer group.
Illinois Tool Works Inc. trades under the code ILT on the Deutsche Börse Xetra in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Illinois Tool Works Inc. (ILT) trades on the Deutsche Börse Xetra in Germany. It last closed at EUR 238.60 on 27 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 212 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 14.8% and over the last three months it fell 4.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Deutsche Börse Xetra
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 66 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.1% | ||
| From 52-week high | -8.4% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -4.4% | ||
| 6-month return | 5.5% | ||
| 12-month return, skipping the last month | 14.9% | ||
| Stability (higher is calmer) | 88 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.1% | ||
| Liquidity | 22 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M EUR | ||
| Zero-volume days | 13.3% | ||
| Income | 67 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.2% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −1.8% |
|---|---|
| 1 month | −0.1% |
| 3 months | −4.4% |
| 6 months | +5.5% |
| 1 year | +14.8% |
| 3 years | +20.0% |
| 5 years | +39.1% |
Signals
| 50-day / 200-day average | 236.84 / 231.50 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.88 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Sep 2026 | USD 1.5299 |
| 30 Jun 2026 | USD 1.4321 |
| 31 Mar 2026 | USD 1.4321 |
| 2 Jan 2026 | USD 1.4321 |
| 30 Sep 2025 | USD 1.4321 |
| 30 Jun 2025 | USD 1.3343 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Deutsche Börse Xetra; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.